SCHEMBL25523282

SCHEMBL25523282

B[C@H]([C@@H](C)N(C)C)n1ccc2cc(OC)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.48
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 1/20 0.43
HTR6 P50406 2/20 0.39
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTR2A P28223 1/20 0.38
ROCK1 Q13464 1/20 0.38
TUBB1 Q9H4B7 1/20 0.37
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
FABP4 P15090 1/20 0.36
PTGS2 P35354 3/20 0.35
PTGS1 P23219 2/20 0.35
AKR1C3 P42330 2/20 0.35
AKR1C2 P52895 2/20 0.35
CDC42 P60953 1/20 0.35
RAC1 P63000 1/20 0.35
CYP1A2 P05177 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25523270 1.00 HTR2C (0.48) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL25523289 1.00 HTR2C (0.48) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL25523295 1.00 HTR2C (0.48) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL25523286 1.00 HTR2C (0.48) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL3332580 0.82 HTR2C (0.52) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL597518 0.79 HTR2C (0.58) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL26500009 0.78 HTR2C (0.48) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL25523318 0.76 HTR2C (0.43) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL25209260 0.75 SLC6A2 (0.42) HTR2CSLC6A2SLC6A4HTR6POLB
SCHEMBL25201002 0.75 SLC6A2 (0.42) HTR2CSLC6A2SLC6A4HTR6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159456-A1 N-SUBSTITUTED INDOLES TERRAN BIOSCIENCES INC (US) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159456-A1 N-SUBSTITUTED INDOLES TPH2, TPH1, AANAT HTR2C 11/4885SLC6A2 25/4885SLC6A4 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.